Helping clients discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.
How we help clients: our global network
Conferences and meetings
We convene experts across the world to share the latest thinking and research at hosted events, such as the McKinsey Cancer Congress Series at the American Society for Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) conferences. In addition, we routinely attend key conferences of the American Association for Cancer Research (AACR), the American Society of Hematology (ASH), and the Society for Immunotherapy of Cancer (SITC).
Publications and perspectives
Our latest insights are featured in peer-reviewed and other journals—for example, the Lancet, on the International Cancer Benchmarking Partnership (ICBP), documenting discrepancies in cancer-survival rates. We also publish with the World Innovation Summit for Health (perspectives on affordable cancer care) and in McKinsey’s Health International (insights on health systems and optimizing clinical care). Our perspectives on specific topics, such as new therapeutic technologies and changes in oncology’s development paradigm, regularly appear in print.
Keynote
McKinsey Cancer Congress Series at ASCO 2023
The McKinsey Cancer Center hosted over 200 participants at the 15th annual McKinsey Cancer Congress Series Symposium during ASCO 2023. This year’s presentation featured a discussion on “From chip to bedside - Oncology in silico R&D”, and also included a vibrant panel discussion with industry-leading experts. For further information on upcoming events, please contact us to be added to our mailing list.
McKinsey Cancer Congress Series at ESMO 2023
The McKinsey Cancer Center also hosted the 5th annual Congress Series Symposium at ESMO 2023 under the theme "Oncology Rewired – Improving patient lives with digital health” where a distinguished panel of experts shared their invaluable insights with over 100 participants.